Home/Filings/4/0000950170-25-110775
4//SEC Filing

Zalevsky Jonathan 4

Accession 0000950170-25-110775

CIK 0000906709other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 9:05 PM ET

Size

8.5 KB

Accession

0000950170-25-110775

Insider Transaction Report

Form 4
Period: 2025-08-19
Zalevsky Jonathan
Chief R&D Officer
Transactions
  • Sale

    Common Stock

    2025-08-19$26.59/sh725$19,27819,668 total
  • Award

    Stock Option

    2025-08-19+16,66616,666 total
    Exercise: $0.50Exp: 2031-12-12Common Stock (16,666 underlying)
Footnotes (5)
  • [F1]Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $26.19 to $27.15 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
  • [F3]On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.
  • [F4]These stock options were granted on December 13, 2023 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.
  • [F5]The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 17, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on August 19, 2025 (subject to remaining time-based vesting requirements).

Documents

1 file

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0001789857

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 9:05 PM ET
Size
8.5 KB